纽约市癌症儿童中的 COVID-19 。
COVID-19 in Children With Cancer in New York City.
机构信息
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
出版信息
JAMA Oncol. 2020 Sep 1;6(9):1459-1460. doi: 10.1001/jamaoncol.2020.2028.
Abstract
This cross-sectional study assesses the risk associated with Coronavirus Disease 2019 for pediatric patients with cancer.
摘要
本横断面研究评估了 2019 年冠状病毒病（COVID-19）对患有癌症的儿科患者的风险。
相似文献
1
COVID-19 in Children With Cancer in New York City.纽约市癌症儿童中的 COVID-19 。
JAMA Oncol. 2020 Sep 1;6(9):1459-1460. doi: 10.1001/jamaoncol.2020.2028.
2
Traveling to New York City to Tackle COVID-19.前往纽约市应对 COVID-19。
Am J Nurs. 2020 Aug;120(8):56-57. doi: 10.1097/01.NAJ.0000694588.29948.0d.
3
Disparities in Cancer Outcomes Due to COVID-19-A Tale of 2 Cities.COVID-19导致的癌症治疗结果差异——两个城市的故事
JAMA Oncol. 2020 Oct 1;6(10):1531-1532. doi: 10.1001/jamaoncol.2020.3327.
4
Cancer Treatment Adaptations in the COVID-19 Era.COVID-19 时代的癌症治疗调整
JCO Oncol Pract. 2020 Jun;16(6):305-307. doi: 10.1200/OP.20.00218. Epub 2020 Apr 23.
5
No change in cesarean section rate during COVID-19 pandemic in New York City.纽约市在新冠疫情期间剖宫产率无变化。
Eur J Obstet Gynecol Reprod Biol. 2020 Oct;253:328-329. doi: 10.1016/j.ejogrb.2020.06.010. Epub 2020 Jun 11.
6
Active and Effective Measures for the Care of Patients With Cancer During the COVID-19 Spread in China.在中国新冠疫情传播期间照顾癌症患者的积极有效措施
JAMA Oncol. 2020 May 1;6(5):631-632. doi: 10.1001/jamaoncol.2020.1198.
7
Rethinking Clinical Trials Reform During the COVID-19 Pandemic.新冠疫情期间对临床试验改革的反思
JAMA Oncol. 2020 Sep 1;6(9):1327-1329. doi: 10.1001/jamaoncol.2020.3142.
8
New York City Innocence Lost: Cardiology in the COVID-19 Pandemic.纽约市的无辜者蒙冤：新冠疫情中的心脏病学
Circulation. 2020 Jun 23;141(25):2039-2041. doi: 10.1161/CIRCULATIONAHA.120.047265. Epub 2020 Apr 7.
9
Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.COVID-19大流行期间的肿瘤护理服务：研究创新与结果的契机。
JCO Oncol Pract. 2020 Aug;16(8):431-434. doi: 10.1200/OP.20.00326. Epub 2020 May 28.
10
Telehealth in Oncology During the COVID-19 Outbreak: Bringing the House Call Back Virtually.COVID-19疫情期间肿瘤学中的远程医疗：虚拟地重拾上门问诊服务
JCO Oncol Pract. 2020 Jun;16(6):289-293. doi: 10.1200/OP.20.00199. Epub 2020 May 4.
引用本文的文献
1
Clinical Outcomes of Pediatric Cancer Patients with COVID-19: A Cross-Sectional Study.新冠肺炎患儿癌症患者的临床结局：一项横断面研究。
Int J Hematol Oncol Stem Cell Res. 2024 Oct 1;18(4):313-322. doi: 10.18502/ijhoscr.v18i4.16756.
2
Challenges in Treating Pediatric Cancer Patients during the COVID-19 Pandemic: Balancing Risks and Care.COVID-19 大流行期间治疗儿科癌症患者的挑战：平衡风险和护理。
Viruses. 2024 Apr 26;16(5):690. doi: 10.3390/v16050690.
3
A comprehensive investigation on the receptor BSG expression reveals the potential risk of healthy individuals and cancer patients to 2019-nCoV infection.对受体 BSG 表达的全面研究揭示了健康个体和癌症患者感染 2019-nCoV 的潜在风险。
Aging (Albany NY). 2024 Mar 13;16(6):5412-5434. doi: 10.18632/aging.205655.
4
SARS-CoV-2 infections in patients enrolled on the Children's Oncology Group standard-risk B-cell acute lymphoblastic leukemia trial, AALL1731.参加儿童肿瘤学组标准风险B细胞急性淋巴细胞白血病试验AALL1731的患者中的新型冠状病毒2型感染情况
EJHaem. 2023 May 10;4(3):745-750. doi: 10.1002/jha2.697. eCollection 2023 Aug.
5
SARS-CoV-2 infections and MIS-C among children: A narrative review.儿童中 SARS-CoV-2 感染和 MIS-C：叙述性综述。
Medicine (Baltimore). 2023 Aug 4;102(31):e34475. doi: 10.1097/MD.0000000000034475.
6
Humoral profiling of pediatric patients with cancer reveals robust immunity following anti-SARS-CoV-2 vaccination superior to natural infection.对癌症患儿的体液分析显示，接种抗 SARS-CoV-2 疫苗后产生了强大的免疫反应，优于自然感染。
Pediatr Blood Cancer. 2023 Aug;70(8):e30473. doi: 10.1002/pbc.30473. Epub 2023 May 30.
7
Determinants of COVID-19 Disease Severity-Lessons from Primary and Secondary Immune Disorders including Cancer.COVID-19 疾病严重程度的决定因素——包括癌症在内的原发性和继发性免疫紊乱的教训。
Int J Mol Sci. 2023 May 14;24(10):8746. doi: 10.3390/ijms24108746.
8
Characteristics & outcomes of cancer patients with COVID-19: A multicentre retrospective study from India.COVID-19 癌症患者的特征和结局：一项来自印度的多中心回顾性研究。
Indian J Med Res. 2022 May-Jun;155(5&6):546-553. doi: 10.4103/ijmr.ijmr_1703_21.
9
Manifestations of COVID-19 infection in children with malignancy: A single-center experience in Jordan.恶性肿瘤患儿新冠病毒感染的表现：约旦的单中心经验
World J Virol. 2022 Sep 25;11(5):321-330. doi: 10.5501/wjv.v11.i5.321.
10
SARS-CoV-2 in immunocompromised individuals.免疫功能低下个体中的 SARS-CoV-2。
Immunity. 2022 Oct 11;55(10):1779-1798. doi: 10.1016/j.immuni.2022.09.006. Epub 2022 Sep 13.
本文引用的文献
1
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery.对入院分娩的女性进行新冠病毒2型普遍筛查。
N Engl J Med. 2020 May 28;382(22):2163-2164. doi: 10.1056/NEJMc2009316. Epub 2020 Apr 13.
2
Epidemiology and clinical features of coronavirus disease 2019 in children.2019年冠状病毒病在儿童中的流行病学及临床特征
Clin Exp Pediatr. 2020 Apr;63(4):125-132. doi: 10.3345/cep.2020.00535. Epub 2020 Apr 6.
3
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
4
Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study.中国浙江 36 例 2019 冠状病毒病（COVID-19）患儿的临床和流行病学特征：一项观察性队列研究。
Lancet Infect Dis. 2020 Jun;20(6):689-696. doi: 10.1016/S1473-3099(20)30198-5. Epub 2020 Mar 25.
5
SARS-CoV-2 Infection in Children.儿童感染新型冠状病毒2型
N Engl J Med. 2020 Apr 23;382(17):1663-1665. doi: 10.1056/NEJMc2005073. Epub 2020 Mar 18.
6
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
Zotero 插件